Katie Duggan’s world was turned upside down when, at just five months pregnant with her second child, she was diagnosed with gestational diabetes.
A normally healthy 30-year-old, Duggan had been taking care of herself, exercising regularly and eating well. But the diagnosis still came as a shock. What makes her story particularly relatable is that she’d had a completely normal pregnancy just two years prior, with her first child.
Warning signs you might be missing
While Duggan’s experience is extreme, researchers warn that many people are unaware of the subtle warning signs of autoimmune diseases like Type 1 diabetes. These can include unexplained weight loss, excessive thirst and fatigue.
The American Diabetes Association estimates that up to 85% of people with Type 1 diabetes do not exhibit noticeable symptoms until the disease has progressed to an advanced stage.
New hope for Type 1 diabetes sufferers
Now, a breakthrough treatment is offering fresh hope to those living with the condition. By harnessing the power of AI, researchers have developed a new approach to treating Type 1 diabetes that could potentially render insulin jabs a thing of the past.
The treatment, known as the “artificial pancreas,” uses AI to monitor blood glucose levels in real-time. It then releases the precise amount of insulin needed to maintain a normal blood sugar balance.
Developed by Dr. Francis Doyle, a researcher at Harvard University, the artificial pancreas has shown remarkable promise in clinical trials. Results suggest that it can reduce the risk of hypoglycemia and improve overall glucose control.
What this means
The significance of this breakthrough cannot be overstated. For millions of people living with Type 1 diabetes, daily insulin injections can be a constant reminder of their condition. The prospect of an artificial pancreas that can perform this task autonomously is a game-changer.
While more research is needed before this treatment becomes widely available, it’s a beacon of hope for those affected by Type 1 diabetes.
